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Ⅲ 
摘 要 
研究背景  近年来，随着国人生活水平的不断提高，痛风在我国的发病率明显
升高，且呈年轻化趋势，严重危害患者的身体健康。急性痛风性关节炎常常是
自限性的，患者在不通过临床干预的情况下，常常在 7-9 天可自行缓解。然而，
目前对于痛风自发缓解的机制的研究是局限的。其具体的自我缓解机制还不是
很清楚。了解其自发缓解的机制有望为治疗复发难治性痛风提供新的治疗策略。
痛风性关节炎（gouty arthritis，GA）是尿酸盐（monosodium urate MSU）从
组织液中析出形成晶体沉积于关节及周围组织，进而引起关节急性炎症反应。
人体内有识别病原体相关分子模式（Pathogen Associated Molecular 
Patterns ,PAMPs）和危险信号相关分子模式（Danger signals related 
molecular Patterns,DAMPs）2 种方式，Toll 样受体（Toll-like receptors, 
TLRs）是人类模式识别受体（PRRS）最主要的一类分子。目前已证实 MSU 晶体
作为一种危险信号，经胞内一系列的信号转导，最终激活 IL-1 和 IL-18，诱导
炎症反应。在痛风中，MSU 沉积于关节中，表现可以是无症状的或者是急性自
限性炎症。MSU 与关节腔中的滑膜细胞，巨噬细胞，以及其他细胞相互反应，
成为痛风炎症反应的初始靶点，诱导中性粒细胞的浸润。MSU 刺激巨噬细胞，
释放炎症介质 TNF-α，IL-1β，CXCL1，CXCL8（IL-8）。MSU 可以被吞噬细胞
吞噬，MSU 通过 TLR2/4 及 MyD88 参与了 TLR2/4 介导的 NF-κB的活化，同时，
TLR2，TLR4 介导 MSU 的吞噬。CD14 分子是是 GPI 锚定蛋白，属细胞表面糖蛋白
家族成员之一。它表达多种细胞表面，如单核细胞，巨噬细胞，中性粒细胞等。
除了 mCD14,CD14 还存在 sCD14 的形式。CD14 分子的生物学效应还不是很清楚。
CD14 分子是 LPS 的受体，在单核细胞表面，LPS 受体 CD14 和 LPS 结合蛋白（LBP）
与 LPS 结合形成一个三分子的复合物，使得单核细胞可以识别 LPS 的存在。CD14
分子充当 TLR2 和 TLR4 分子的共受体而增强 LPS 对于 TLR2 和 TLR4 的反应。鉴
于，CD14 分子对于 MSU 诱导中性粒细胞引起炎症反应是必须的。是否 CD14 也
参与痛风自发缓解目前仍不清楚，因此探究 CD14 分子在痛风中自发缓解的机制
有望为痛风的治疗寻找新的靶点。
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研究目的 探究CD14分子在痛风中自发缓解的作用及机制。 
研究方法 Elisa检测痛风病人（n=40）与正常人（n=31）上清sCD14，并分析其
与CRP的相关性，收集正常人外周血，提取PBMC，MSU及LPS刺激，流式检测CD14
分子，以及CD14+cell凋亡情况，同时ELISA检测培养上清中的sCD14。QPCR检测
痛风病人PBMC中CD14mRNA. 
实验结果 sCD14在痛风病人中是减低的（p=0.0001），同时，sCD14与CRP呈正相
关的关系(p=0.0026,r=0.48)，另外，sCD14在CRP<9的患者中较CRP>9的患者中是
低的(p=0.0140)。正常人PBMC分别以LPS 0μg/ml,0.1μg/ml,1μg/ml,10μg/ml 刺激
16h流式检测CD14占PBMC比例，Mann-Whitney U test统计分析无差异。正常人PBMC
以MSU 0μg/ml,30μg/ml,100μg/ml,300μg/ml刺激16h.流式检测CD14占PBMC的比
例，Mann-Whitney U test 统计分析，刺激浓度为30μg/ml的PBMC与未刺激的PBMC
中CD14所占比例无差异。而刺激浓度为100μg/ml PBMC中CD14所占比（p=0.0286）
和 300μg/ml PBMC 中 CD14 所占 比例 （ p=0.0286 ） 明显 减低 。 PBMC 以 LPS 
0μg/ml,0.1μg/ml,1μg/ml,10μg/ml 刺激16h, elisa检测上清sCD14统计分析无差
异 。 PBMC MSU0μg/ml,30μg/ml,100μg/ml,300μg/ml 刺 激 elisa 检 测 上
sCD14，刺激浓度为30μg/ml, 统计分析无差异, 100μg/ml(p=0.0296),300μg/ml
(p=0.0278)上清中的sCD14明显下降。正常人PBMC分别以LPS 0μg/ml,0.1μg/ml,1μg/ml,10μ
g/ml 刺激16h流式检测CD14占CD68+比例，Mann-Whitney U test 统计分析无差
异。正常人PBMC MSU0μg/ml,30μg/ml,100μg/ml,300μg/ml刺激16h.流式检测CD14占
CD68+的比例，Mann-Whitney U test 统计分析，刺激浓度为30μg/ml的PBMC与未
刺激的PBMC中CD14占CD68+细胞比例无差异。而刺激浓度为100μg/ml PBMC中CD14
占CD68+细胞比例（p=0.0357）和300μg/ml PBMC中CD14占CD68+比例（p<0.0001）
明显减低。正常人PBMC MSU 0μg/ml,30μg/ml,100μg/ml,300μg/ml刺激刺激16h后，
胞内染色CD14，并未发现CD14. 随着MSU刺激浓度的增加，CD14+凋亡细胞并没有
明显变化。另外，sCD14减少并非是与MSU结合导致其减少，然而痛风病人PBMC
中CD14mRNA的合成较正常人增高(p=0.0252)。 
结论  我们在痛风病人血清中检测到 sCD14 是减低的，同时在体外实验中发现
正常人 PBMC 在 MSU 刺激下单核细胞上 CD14 是明显减低的，而在 LPS 刺激下单
核细胞上的 CD14 无明显变化，另外，我们检测到上清中 sCD14 在 LPS 刺激下
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Ⅴ 
是无变化的，而在 MSU 刺激下，SCD14 是明显降低的。我们推测，PBMC 在 MSU
刺激下 CD14 以及 sCD14 的减低，可能参与了痛风的自发缓解机制。另外，我
们在胞内染色 CD14，并未发现 CD14，同时，随着 MSU 刺激浓度的增加，CD14+
凋亡细胞并没有明显变化。但痛风病人 PBMC 中 CD14mRNA 的合成较正常人增高。
我们推测 CD14 的减低并非是由于 mRNA 合成的减低而减低，可能存在其他转录
后的调控机制使得 CD14 分子的减少。 
关键词 CD14 SCD14 痛风性关节炎 MSU  
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Abstract 
Research background  With the growth in the living standard,the morbidity of 
gout has obviously increased .It has threated the health of human . An interesting 
feature of acute gout is the self-limiting nature of the inflammatory flare. In the 
absence of clinical intervention, a gouty episode will spontaneously resolve within 
7–10 days. The mechanism of acute gout is complicated.There are PAMPs and 
DAMPs forms in human.TLRs and NLRs are two mainly molecules in PRRS. the 
deposition of monosodium urate (MSU) crystals in articular joints as foreign matters 
are the trigger to induce acute imflammatory reaction.But,the pathogenesis is not 
clearly.In gout, the deposition of monosodium urate (MSU) crystals in articular 
joints and bursal tissues can be asymptomatic or be associated with the pathogenesis 
of acute, episodic, selflimiting joint inflammationThe interaction of MSU crystals 
with synovial lining cells, macrophages, and other resident cells in the joint appears 
to be the primary trigger for the acute neutrophil ingress that drives episodes of 
gouty arthritis. The induction by MSU crystals of phagocyte release of mediators, 
including arachidonate metabolites, the cytokines TNF-α, IL-1β, CXCL1 (GRO
α), CXCL8(IL-8). MSU crystals are ingested by phagocytes. Significantly, MSU 
crystals functionally engage the canonical signaling pathway from TLR2 to NF-κB 
activation mediated by the shared TLR and IL-1 receptor adaptor protein MyD88. 
TLR2 and TLR4 each mediate macrophage uptake of the MSU crystal in vitro and 
MSU-crystal-induced induced inflammation in vivo.CD14 is a GPI-anchored protein 
constitutively expressed on the surface of various cells, including monocytes, 
macrophages, polymorphonuclear neutrophils,Aside from this membrane-bound 
(mCD14) state, CD14 is also found in a circulating soluble (sCD14) state. The exact 
role of CD14 in physiological and pathological situations is not well defined. CD14 
was initially described as a specific receptor for LPS, a compound from the outer cell 
wall of Gram-negative bacteria. At the monocyte surface, the LPS receptor mCD14 
and the LPS-binding protein (LBP) interact with LPS and form a high affinity 
trimolecular complex that allows monocytes to detect the presence of LPS. The 
pattern recognition molecule CD14 serves as a shared TLR2 and TLR4 adaptor
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 molecule that increases TLR2- and TLR4-mediated functional responses to specific 
agonists, including peptidoglycan and LPS, respectively. CD14 is essential for a 
full-blown MSU crystal-induced neutrophilic inflammatory response. So, exploring 
CD14 molecules spontaneously in gout relief mechanism is expected to find a new 
targets for the treatment of gout. 
Research purpose  Exploring CD14 molecules spontaneously in gout relief 
mechanism is expected to find a new targets for the treatment of gout. 
Methods sCD14was detected by ELISA in the serum of patients (n=40) with gout 
and healthy control (n=31) and we analyze the correlation between sCD14 and CRP. 
We Collected peripheral blood from healthy control and then the PBMCs were 
isolated.The expression of CD14 was detected by flow cytometry and the apoptotic 
cell of CD14+cell was detected after PBMC stimulated by MSU and LPS.Then, 
mRNA of CD14 in gout patient was detected by Q-PCR. 
Results  sCD14 decreased in gout patients (p=0.0001)Positive correlation between 
sCD14 and CRP in gout patients. Drecreased sCD14 in gout patients with CRP<9. 
PBMC from healthy volunteers was stimulated for 16h by LPS with 
0μg/ml,0.1μg/ml,1μg/ml,10μg/ml.CD14 expression was detected by flow cytomety. 
There is no difference to compare the data respectively analyzed by Mann-Whitney 
Utest.PBMC from healthy volunteers was stimulated for 16h by MSU with 
0μg/ml,30μg/ml,100μg/ml,300μg/ml. CD14 expression was detected by flow 
cytomety. There is no difference between PBMC stimulated by 0μg/ml and 30μg/ml. 
However, obviously decreased CD14 expression appeared in PBMC stimulated by 
MSU with 100μg/ml(p=0.0286)and 300μg/ml(p=0.0286). PBMC from healthy 
volunteers was stimulated for 16h by LPS with 0μg/ml、100ng/ml、1μg/ml、
10μg/ml.sCD14 was detected by elisa. There is no difference to compare the data 
respectively analyzed by Mann-Whitney U test. PBMC from healthy volunteers was 
stimulated for 16h by MSU with 0μg/ml,30μg/ml,100μg/ml,300μg/ml.sCD14 was 
detected by elisa. There is no difference between PBMC stimulated by 0μg/ml and 
30μg/ml. However, obviously decreased sCD14 appeared in PBMC stimulated 
byMSU with 100μg/ml(p=0.0296)and 300μg/ml(p=0.0278). PBMC from healthy 
volunteers was stimulated for 16h by LPS with                                
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0μg/ml,0.1μg/ml,1μg/ml,10μg/ml.CD14 expression in CD68+ cell was detected by 
flow cytomety. There is no difference to compare the data respectively analyzed by 
Mann-Whitney U test.PBMC from healthy volunteers was stimulated for 16h by 
MSU with 0μg/ml,30μg/ml,100μg/ml,300μg/ml.CD14 expression in CD68+ cell was 
detected by flow cytomety. There is no difference between PBMC stimulated by 
0μg/ml and 30μg/ml. However, obviously decreased CD14 expression appeared in 
the CD68+cell of PBMC stimulated by MSU with 100μg/ml(p=0.0286)and 
300μg/ml(p=0.0286). we did not find CD14 in Intracellular cell and the number of 
apoptotic cells in CD14+ cells was not increased.The reason of decreased sCD14 
was not the combination of MSU and sCD14.However,the CD14 expression of 
mRNA in gout patients increased(p=0.0252). 
Conclusion  sCD14 decreased in gout patients and Positive correlation between 
sCD14 and CRP in gout patients. Drecreased sCD14 in gout patients with CRP<9. 
The CD14 expression of PBMC has decreased after PBMC was stimulated by 
different concentration of MSU .Then, the CD14 expression of PBM was no 
difference after PBMC was stimulated by different concentration of LPS.At the same 
time,sCD14 decreased in supernatant of PBMC stimulated by different concentration 
of MSU.however, sCD14 was no difference after PBMC was stimulated by different 
concentration of LPS. we did not find CD14 in Intracellular cell and the number of 
apoptotic cells in CD14+ cells was not increased.The reason of decreased sCD14 
was not the combination of MSU and sCD14.However,the CD14 expression of 
mRNA in gout patients increased.We speculat that there is other mechanisms of 
CD14 decreased. 
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英文缩略词表（按字母顺序） 
 
 
GA         gout arthritis                         痛风性关节炎 
PBS        buffered saline                        磷酸盐缓冲液 
rpm        Round per minum                        每分钟转速 
g          Gram                                   克 
ml         Milliliter                             毫升 
EP         Eppendorf                              微量离心管 
μl         Microliter                             微升 
OD         Optical density                        光密度 
min        Minute                                 分钟 
PBMCs      peripheral blood mononuclear cells     外周血单个核细胞 
CRP        C-reactive protein                     C 反应蛋白 
pH         Potential of hydrogen                  酸碱度 
LPS        lipopolysaccharide                     脂多糖 
MSU        monosodium urate                       尿酸盐结晶 
TLRs       Toll-like receptors                    Toll 样受体 
NLRs       Nod-like receptors                     Nod 样受体 
cox-2      cyclooxygenase-2                       环氧化酶-2 
PGE2       prostaglandine                         前列腺素 E2  
PAMPs      Pathogen Associated Molecular Patterns 病原体相关分子模式 
DAMPs     Danger signals related molecular Pattern 危险信号相关分子模
式 
NF-κB     nuclear factor-κB                     转录因子-κB 
AP-1       activator protein 1                    活化蛋白-1 
sCD14      solubility CD14                        可溶性 CD14    
缩略词 英文名称 中文名称 
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NSAIDS    non-steroidal anti-inflammatory drugs   非甾体抗炎药 PGN       
peptidoglycan                                     肽聚糖 
ELISA     enzyme-linked immuno sorbent assay      酶联免疫吸附测定 
FCM       flow cytometry                          流式细胞术 
Ab        antibody                                抗体 
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前言  
5 
前 言 
近年来，随着国人生活水平的不断提高，痛风在我国的发病率明显升高，且呈
年轻化趋势，严重危害患者的身体健康。急性痛风性关节炎常常是自限性的，患
者在不通过临床干预的情况下，常常在7-9天可自行缓解。然而，目前对于痛风
自发缓解的机制的研究是局限的。其具体的自我缓解机制还不是很清楚。了解其
自发缓解的机制有望为治疗复发难治性痛风提供新的治疗策略。 
CD14分子是GPI锚定蛋白，属细胞表面糖蛋白家族成员之一。人CD14 的编码基
因定位于5号染色体长臂上5q23 -q31
[1]。CD14基因包含两个外显子，他们编码CD14
的mRNA,CD 14分子由375个氨基酸构成。CD14分子包含7个重复的亮氨酸，它类似
于TLR受体上结合PAMP的部分。CD14分子缺乏跨膜区，因而CD14分子不能单独向
胞内传导信号[2]。CD14表达与多种细胞的表面，如单核巨噬细胞，中性粒细胞，
软骨细胞
[3]，B细胞[4]，树突细胞[5]，角质细胞[6]以及人的肠上皮细胞[7]。CD14分
子在人内存在两种形式-mCD14及sCD14[8, 9]。mCD14是一种分子量为53 -55KD的糖
蛋白而sCD14 可能是两种分子量的蛋白混合物, 一种为49KD,较mCD14缺少GPI螯
和物, 它是从细胞膜上直接脱落的;另一种为55KD, 较mCD14只少插在细胞膜上
的二酰基甘油组分, 它是CD14 分子在胞内加GPI尾之前从细胞内释放出来的。
CD14是细菌脂多糖(LPS)的受体, [10] 其主要功能是在脂多糖结合蛋白(LBP)的协
作下结合LPS并引起细胞活化。通常它以聚合体形式与CD14 结合[11]。CD14 也是
凋亡细胞表面的细胞间粘附分子-3、革兰氏阳性菌细胞壁成分肽聚糖
(peptidoglycan, PGN)[12]、多种病原体[13]、人的热休克蛋白60[14]的受体。CD14 与
Toll 样受体(TLRs)一样是重要的模式识别受体, 在机体抵抗LPS 、PGN 、LTA 等
多种病原体成分的反应中发挥着重要的作用。人类TLR2 是LPS 的信号转导分子, 
它的活化有赖于LPS 结合蛋白(LBP)和CD14 的存在, LPS 激活TLR2可以引起NF-
κB 的活化。同样TLR4 也是介导细胞与LPS 反应的关键分子[15, 16]。CD14 与LPS
结合后, 募集TLR4 、MD-2 等LPS 受体分子, 形成LPS受体复合体, 由TLR4 胞内
段与MyD88 结合启动LPS信号转导通路, 最终引起NF-κB 的活化[17, 18]。再者，有
研究发现CD14 可以使得LPS 复合物在内体中的重分布，因此当CD14缺乏，LPS 不
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